Hegseth Orders Annual Testosterone Tests for U.S. Troops 30+ as Pentagon Leaves Rules Unclear
Updated
Updated · PBS NewsHour · Jul 26
Hegseth Orders Annual Testosterone Tests for U.S. Troops 30+ as Pentagon Leaves Rules Unclear
3 articles · Updated · PBS NewsHour · Jul 26
Summary
A July 15 Pentagon statement confirmed mandatory annual testosterone-deficiency screening for all active-duty and reserve service members age 30 and older, with younger troops allowed to opt in voluntarily.
Hegseth cast the policy as part of a "High-T Department of War," saying any treatment would be optional and aimed at restoring natural capability rather than artificially enhancing performance.
Doctors say the program faces medical gray areas: normal male testosterone spans roughly 300 to 1,000 nanograms per deciliter, levels fall about 1% to 2% a year after 30, and no single cutoff defines deficiency.
Clinical guidance typically requires symptoms plus at least two low morning blood tests before diagnosing low testosterone, while replacement therapy can improve energy and libido but also risks infertility, blood clots and stroke.
The Defense Department declined to answer many implementation questions, leaving unclear how screening thresholds, follow-up testing and treatment decisions would work across men, women and intersex service members.
Will the military's unprecedented mandatory hormone screening force perfectly healthy soldiers into risky treatments just to protect their careers?
With military life causing chronic stress, is the Pentagon's new testosterone screening treating a symptom rather than the root cause of troop fatigue?